Emma Reeve

Emma Reeve has served as a member of the board of directors since October 2020. Ms. Reeve has served as senior vice president and chief financial officer of Constellation since October 2017 and treasurer of Constellation since December 2017. Ms. Reeve served as corporate controller of PAREXEL International Corporation, or PAREXEL, a life sciences consulting firm and contract research organization, from September 2014 to October 2017 and as interim chief financial officer and corporate controller of PAREXEL from July 2016 to May 2017. Ms. Reeve served as head of finance and administration at Novartis Pharma Schweiz, a pharmaceutical company, from May 2012 to August 2014 and as vice president, global head business planning and analysis for Novartis Vaccines and Diagnostics, a division of Novartis AG, a healthcare company, from January 2008 to April 2012. She served as chief financial officer of Inotek Pharmaceuticals Inc., a biotechnology company, from 2006 to 2007, as senior director of research operations at Merck Research Laboratories, a pharmaceutical company, from 2004 to 2006 and as chief financial officer of Aton Pharma, Inc., a biotechnology company, from 2002 to 2004. Ms. Reeve also worked at Bristol-Myers Squibb Company, a biopharmaceutical company, from 1994 to 2002. Ms. Reeve serves on the board of directors of PTC Therapeutics, Inc., a public biopharmaceutical company. Ms. Reeve is an associate of the Institute of Chartered Accountants in England & Wales. Ms. Reeve received a B.Sc. in computer science from Imperial College, University of London.